Xenografted human microglia display diverse transcriptomic states in response to Alzheimer’s disease-related amyloid-β pathology

Renzo Mancuso,Nicola Fattorelli,Anna Martinez-Muriana,Emma Davis,Leen Wolfs,Johanna Van Den Daele,Ivana Geric,Jessie Premereur,Paula Polanco,Baukje Bijnens,Pranav Preman,Lutgarde Serneels,Suresh Poovathingal,Sriram Balusu,Catherine Verfaillie,Mark Fiers,Bart De Strooper

DOI: https://doi.org/10.1038/s41593-024-01600-y

IF: 25

2024-03-27

Nature Neuroscience

Abstract:Abstract Microglia are central players in Alzheimer’s disease pathology but analyzing microglial states in human brain samples is challenging due to genetic diversity, postmortem delay and admixture of pathologies. To circumvent these issues, here we generated 138,577 single-cell expression profiles of human stem cell-derived microglia xenotransplanted in the brain of the App NL-G-F model of amyloid pathology and wild-type controls. Xenografted human microglia adopt a disease-associated profile similar to that seen in mouse microglia, but display a more pronounced human leukocyte antigen or HLA state, likely related to antigen presentation in response to amyloid plaques. The human microglial response also involves a pro-inflammatory cytokine/chemokine cytokine response microglia or CRM response to oligomeric Aβ oligomers. Genetic deletion of TREM2 or APOE as well as APOE polymorphisms and TREM2 R47H expression in the transplanted microglia modulate these responses differentially. The expression of other Alzheimer’s disease risk genes is differentially regulated across the distinct cell states elicited in response to amyloid pathology. Thus, we have identified multiple transcriptomic cell states adopted by human microglia in a multipronged response to Alzheimer’s disease-related pathology, which should be taken into account in translational studies.

neurosciences

What problem does this paper attempt to address?

This paper aims to address the issue of microglia responses related to amyloid - β (Aβ) pathology in Alzheimer's disease (AD). Specifically, the researchers focused on:

1. **Responses of human microglia to Aβ pathology**: By transplanting human - stem - cell - derived microglia into the brains of mice expressing Aβ pathology, the researchers attempted to understand the specific responses of these cells when faced with Aβ pathology. This includes identifying cell types in different transcriptome states, such as Disease - associated microglia (DAM), Antigen - presenting response (HLA), Cytokine response (CRM), etc.

2. **Differences between human microglia and mouse microglia responses**: The study found that the responses of human microglia to Aβ pathology are significantly different from those of mouse microglia, especially in terms of HLA and CRM states, which were not observed in the mouse model. This indicates that human microglia may have more complex response mechanisms.

3. **The role of gene regulation in microglia state transitions**: The study also explored the roles of the TREM2 and APOE genes in microglia state transitions. TREM2 was confirmed to be a key factor in inducing DAM and HLA states, while APOE plays an important role in the transition from DAM to HLA. These findings help to understand how genetic factors influence the responses of microglia to Aβ pathology.

4. **The effects of different forms of Aβ pathology on microglia**: The study further analyzed the different effects of different forms of Aβ pathology (such as Aβ plaques and soluble Aβ oligomers) on microglia. The results showed that soluble Aβ oligomers mainly induce the CRM state without causing an HLA response, which provides clues for further understanding the molecular mechanisms of Aβ pathology.

Through these studies, the paper provides a new perspective for understanding the complex responses of microglia in Alzheimer's disease and potential targets for future treatment strategies.